Form EFFECT Edesa Biotech, Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 13, 2026 4:05 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ripple News: XRP ETF Demand Stays Strong, but Best Altcoin To Buy Now AlphaPepe Offers the Earlier High-Upside Setup
- Yutong Opens Its First Comprehensive Service Center in Europe
- Mercuria Energy Group Limited announces successful closure of new JPY 145.3 billion three-year Samurai Term Loan Facility
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share